Samartha Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 11-01-2025
- Paid Up Capital ₹ 3.73 Cr
as on 11-01-2025
- Company Age 23 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.50 Cr
as on 11-01-2025
- Revenue -41.75%
(FY 2021)
- Profit -47.69%
(FY 2021)
- Ebitda -47.28%
(FY 2021)
- Net Worth 13.04%
(FY 2021)
- Total Assets 7.71%
(FY 2021)
About Samartha Hospital And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.73 Cr.
The company currently has active open charges totaling ₹16.50 Cr.
Jyoti Bhangale, Rashmi Badhe, Rakesh Badhe, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MH2001PTC133339
- Company No.
133339
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samartha Hospital And Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Bhangale  | Director | 11-Sep-2001 | Current |
| Rashmi Badhe | Director Appointed In Casual Vacancy | 09-Mar-2022 | Current |
| Rakesh Badhe | Director Appointed In Casual Vacancy | 19-Feb-2022 | Current |
| Arjun Bhangale | Director | 11-Sep-2001 | Current |
Financial Performance of Samartha Hospital And Research Centre.
Samartha Hospital And Research Centre Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 41.75% decrease. The company also saw a substantial fall in profitability, with a 47.69% decrease in profit. The company's net worth Soared by an impressive increase of 13.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samartha Hospital And Research Centre?
In 2021, Samartha Hospital And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 22 Aug 2022 | ₹16.50 Cr | Open |
How Many Employees Work at Samartha Hospital And Research Centre?
Unlock and access historical data on people associated with Samartha Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samartha Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samartha Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
